Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer

NCT01469598 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Carcinoma
Recurrent Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Gemcitabine/Docetaxel

Sponsor

Samsung Medical Center